Table 1.
Carcinogenic factors involved in hepatocellular carcinoma in patients with type B cirrhosis[1]
| Variable | n |
Univariate analysis |
Multivariate analysis |
||||
| P-value1 | RR2 | 95% CI | P-value3 | RR2 | 95% CI | ||
| ALT (IU/L) | |||||||
| ≥ 100 | 14 | 0.0083 | 2.044 | 1.098-4.677 | 0.025 | 4.525 | 1.202-17.030 |
| < 100 | 51 | 1.000 | 1.000 | ||||
| LDH (IU/L) | |||||||
| ≥ 480 | 30 | 0.0138 | 2.000 | 0.878-4.558 | NS (0.081) | 2.880 | 0.881-9.412 |
| < 480 | 35 | 1.000 | 1.000 | ||||
| HBV-DNA (LGE/mL) | |||||||
| ≥ 3.7 | 46 | 0.0082 | 2.836 | 1.269-6.340 | 0.014 | 7.712 | 1.511-39.365 |
| < 3.7 | 19 | 1.000 | 1.000 | ||||
1
P-values were obtained by using the log-rank test;
2
Relative risks were calculated by comparing classes using a Cox regression analysis;
3
P-value were obtained by using a Cox regression analysis. HBV: Hepatitis B virus; ALT: Alanine aminotransferase; LDH: Lactate dehydrogenase; NS: Not significant.